Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Birociclib - Jilin Sihuan Pharmaceutical/XuanZhu Pharma

Next Previous
X
Search
Drug Profile

Birociclib - Jilin Sihuan Pharmaceutical/XuanZhu Pharma

Alternative Names: XZP 3287

Latest Information Update: 09 Jul 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Jilin Sihuan Pharmaceutical; XuanZhu Pharma
  • Class Amides; Amines; Antineoplastics; Cycloparaffins; Piperazines; Pyridines; Pyrimidines; Pyrroles; Small molecules; Succinic acids
  • Mechanism of Action Cyclin-dependent kinase 4 inhibitors; Cyclin-dependent kinase 6 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase III Breast cancer
  • Phase I/II Solid tumours
  • No development reported Brain cancer

Most Recent Events

  • 31 May 2024 Efficacy and adverse events data from phase III BRIGHT-2 trial presented at 60th Annual Meeting of the American Society of Clinical Oncology (ASCO-2024)
  • 20 Oct 2023 Adverse events and efficacy data from a phase I/II trial in Breast cancer presented at 48th European Society for Medical Oncology Congress (ESMO-2023)
  • 27 Jun 2023 Chemical structure information added

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top